JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 86 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 2.97 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $925 | -54.4% | 500,000 | -72.7% | 0.00% | 0.0% |
| Q4 2022 | $2,030 | -99.2% | 1,828,681 | +2110.2% | 0.00% | – |
| Q2 2022 | $251,000 | -56.8% | 82,739 | +19.0% | 0.00% | – |
| Q4 2021 | $581,000 | -67.6% | 69,540 | -71.2% | 0.00% | -100.0% |
| Q3 2021 | $1,792,000 | -42.5% | 241,225 | -47.4% | 0.00% | -50.0% |
| Q2 2021 | $3,117,000 | +70.3% | 458,316 | +157.2% | 0.00% | +100.0% |
| Q1 2021 | $1,830,000 | +446.3% | 178,228 | +272.1% | 0.00% | – |
| Q4 2020 | $335,000 | +79.1% | 47,895 | +108.9% | 0.00% | – |
| Q3 2020 | $187,000 | +71.6% | 22,929 | +45.6% | 0.00% | – |
| Q2 2020 | $109,000 | -65.3% | 15,745 | -76.2% | 0.00% | -100.0% |
| Q1 2020 | $314,000 | -44.0% | 66,126 | +2.9% | 0.00% | 0.0% |
| Q4 2019 | $561,000 | +6.2% | 64,289 | -59.5% | 0.00% | 0.0% |
| Q3 2019 | $528,000 | -28.2% | 158,583 | -27.3% | 0.00% | 0.0% |
| Q4 2018 | $735,000 | -82.3% | 218,024 | -65.9% | 0.00% | -80.0% |
| Q3 2018 | $4,162,000 | -20.0% | 640,261 | -5.7% | 0.01% | -28.6% |
| Q2 2018 | $5,202,000 | -34.3% | 679,177 | +91.6% | 0.01% | -30.0% |
| Q1 2018 | $7,923,000 | +152.6% | 354,496 | +44.1% | 0.01% | +150.0% |
| Q4 2017 | $3,137,000 | +235.9% | 246,021 | +310.4% | 0.00% | +300.0% |
| Q3 2017 | $934,000 | -67.5% | 59,953 | -70.7% | 0.00% | -80.0% |
| Q2 2017 | $2,873,000 | -55.5% | 204,746 | -30.3% | 0.01% | -58.3% |
| Q1 2017 | $6,462,000 | – | 293,862 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
| TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
| Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
| Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
| Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
| PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
| Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
| Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
| ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |